A randomized trial of telemedicine efficacy and safety for nonacute headaches.

ABSTRACT:

Objective

To evaluate long-term treatment efficacy and safety of one-time telemedicine consultations for nonacute headaches.

Methods

We randomized, allocated, and consulted nonacute headache patients via telemedicine (n = 200) or in a traditional manner (n = 202) in a noninferiority trial. Efficacy endpoints, assessed by questionnaires at 3 and 12 months, included change from baseline in Headache Impact Test-6 (HIT-6) (primary endpoint) and pain intensity (visual analogue scale [VAS]) (secondary endpoint). The primary safety endpoint, assessed via patient records, was presence of secondary headache within 12 months after consultation.

Results

We found no differences between telemedicine and traditional consultations in HIT-6 (p = 0.84) or VAS (p = 0.64)

SUBMITTER: Muller KI 

PROVIDER: S-EPMC5501933 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature